Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:494-499
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karjalainen, J.
Right arrow Articles by Kontula, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karjalainen, J.
Right arrow Articles by Kontula, K.

Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes

Jouko Karjalainen, MD*, Urho M. Kujala, MD{dagger}, Anu Stolt, MD{dagger}, Matti Mäntysaari, MD*, Matti Viitasalo, MD{ddagger}, Katariina Kainulainen, MD{ddagger} and Kimmo Kontula, MD{ddagger}

* Central Military Hospital, Helsinki, Finland
{dagger} Unit for Sports and Exercise Medicine, Institute of Biomedicine, University of Helsinki, Helsinki, Finland
{ddagger} Department of Medicine, University of Helsinki, Helsinki, Finland



View larger version (24K):

[in a new window]
 
Figure 1 Left ventricular mass in endurance athletes with different genotypes of angiotensinogen (AGT) gene M235T polymorphism. Solid squares = mean; boxes = ±SE; error bars = 95% confidence intervals.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement